Evidence map›Paper›PMID 37763102›Full record

ArticleJournal of personalized medicine2023

In Systemic Sclerosis Patients, Peripheral Blood CD21

Chiara Pellicano, Amalia Colalillo, Valeria Carnazzo, Serena Redi, Valerio Basile, Mariapaola Marino, Umberto Basile, Edoardo Rosato

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of personalized medicine, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 39% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 1 country.

Chiara PellicanoDepartment of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Amalia ColalilloDepartment of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.
Valeria CarnazzoUOC of Clinical Pathology DEA II Level, Hospital Santa Maria Goretti-ASL Latina, 04100 Latina, Italy.
Serena RediUOC of Clinical Pathology DEA II Level, Hospital Santa Maria Goretti-ASL Latina, 04100 Latina, Italy.
Valerio BasileClinical Pathology and Cancer Biobank IRCCS Regina Elena National Cancer Institute, 00128 Rome, Italy.
Mariapaola MarinoDipartimento di Medicina e Chirurgia Traslazionale, Sezione di Patologia Generale, Università Cattolica del Sacro Cuore, Fondazione Policlinico Universitario A. Gemelli, 00168 Rome, Italy.ORCID 0000-0001-9155-6378
Umberto BasileUOC of Clinical Pathology DEA II Level, Hospital Santa Maria Goretti-ASL Latina, 04100 Latina, Italy.ORCID 0000-0002-8328-2570
Edoardo RosatoDepartment of Translational and Precision Medicine, Sapienza University of Rome, 00185 Rome, Italy.ORCID 0000-0002-7417-8093
Ospedale Santa Maria Goretti · ITSapienza University of Rome · ITIstituti di Ricovero e Cura a Carattere Scientifico · ITUniversità Cattolica del Sacro Cuore · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Systemic sclerosis (SSc) patients have an increased frequency of CD21

Indexed as

arthritisCD21lowDAS28IL-21IL-4jointsystemic sclerosis

Identifiers

PMID37763102
PMCPMC10532941
OpenAlexW4386283137

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.